| 产品详情 |
| Edit |   |
| Product Name | Osteoprotegerin (OPG, Osteoclastogenesis Inhibitory Factor, OCIF) Recombinant, Human |
| Description | Purity ≥98% by SDS-PAGE and HPLC. Endotoxin: ≤0.1ng/ug (1EU/ug). Human OPG (Osteoprotegerin, also know as OCIF Osteoclastogenesis inhibitory factor), is a member of the TNF receptor superfamily. Recombinant human OPG/OCIF specifically acts on bone tissues and increases bone mineral density and bone volume associated with a decrease of active osteoclast number. Recombinant human OPG is a 19.9kD protein, containing 175 amino acid residues, comprising the extra-cellular domain of OPG. Amino Acid Sequence: METFPPKYLH YDEETSHQLL CDKCPPGTYL KQHCTAKWKT VCAPCPDHYY TDSWHTSDEC LYCSPVCKEL QYVKQECNRT HNRVCECKEG RYLEIEFCLK HRSCPPGFGV VQAGTPERNT VCKRCPDGFF SNETSSKAPC RKHTNCSVFG LLLTQKGNAT HDNICSGNSE STQK Biological Activity: Determined by its ability to neutralize the stimulation of U937 cells treated with 10ng/ml of soluble RANKL (sRANKL). |
| Size | 10ug, 50ug |
| Concentration | n/a |
| Applications | n/a |
| Other Names | n/a |
| Gene, Accession, CAS # | n/a |
| Catalog # | O8065-01 |
| Price | |
| Order / More Info | Osteoprotegerin (OPG, Osteoclastogenesis Inhibitory Factor, OCIF) Recombinant, Human from UNITED STATES BIOLOGICAL |
| Product Specific References | n/a |
| 产品资料 |
|
|